<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Stanniocalcin 1 (STC1), originally described as an antihypercalcemic hormone in fish, is highly expressed in differentiated mammalian neurons </plain></SENT>
<SENT sid="1" pm="."><plain>Mild hypoxic treatment and focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induce upregulation of STC1 in the brain </plain></SENT>
<SENT sid="2" pm="."><plain>These findings prompted us to investigate whether STC1 contributes to neuroprotection after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and whether STC1 is required for development of ischemic tolerance </plain></SENT>
<SENT sid="3" pm="."><plain>We induced 60 minutes of temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in <z:mp ids='MP_0002169'>wild type</z:mp> (WT) and STC1-deficient mice (STC1(-/-)) with or without prior hypoxic preconditioning (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e>, 8% oxygen for 6 hours followed by reoxygenation for 24 hours) </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> sizes, neurological scores, and Stc1, Stc2, and Il-6 mRNA brain levels were measured 24 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, we examined blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) integrity (Evans Blue fluorescence) under <z:mpath ids='MPATH_458'>normal</z:mpath> conditions and 0 and 24 hours after <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>STC1(-/-) and WT mice developed brain <z:mpath ids='MPATH_124'>infarcts</z:mpath> of similar size </plain></SENT>
<SENT sid="7" pm="."><plain>In both strains, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> triggered ischemic tolerance with similar reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="8" pm="."><plain>However, STC1(-/-) mice had worse neurological scores in both scenarios </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> induced upregulation of STC1 and STC2 in WT mice and of STC2 in STC1(-/-) mice </plain></SENT>
<SENT sid="10" pm="."><plain>Ischemic STC1(-/-) mice showed significantly lower Il-6 mRNA expression than ischemic WT mice </plain></SENT>
<SENT sid="11" pm="."><plain>Evans Blue fluorescence levels showed no difference in between WT and STC1(-/-) mice under evaluated conditions, thus <z:chebi fb="2" ids="33602">BBB</z:chebi> integrity is preserved despite STC1 deficiency </plain></SENT>
<SENT sid="12" pm="."><plain>STC1 was not crucial for the development of ischemic tolerance triggered by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HPC</z:e> or for preserving <z:chebi fb="2" ids="33602">BBB</z:chebi> integrity but may be involved in functional recovery after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>